Article info
PDFEBM opinion and debate
Rare adverse events in clinical trials: understanding the rule of three
- Correspondence to Dr Igho J Onakpoya, Nuffield Department of Primary Care Health Sciences, University of Oxford, Centre for Evidence-Based Medicine, Oxford OX2 6GG, UK; igho.onakpoya{at}phc.ox.ac.uk
Citation
Rare adverse events in clinical trials: understanding the rule of three
Publication history
- Accepted December 7, 2017
- First published January 24, 2018.
Online issue publication
January 26, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.